Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Depreciation and Depletion: 2018-2024

Historic Depreciation and Depletion for Bicycle Therapeutics (BCYC) over the last 6 years, with Jun 2024 value amounting to $1.6 million.

  • Bicycle Therapeutics' Depreciation and Depletion changed negligibly% to $1.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $6.6 million, marking a year-over-year increase of 10.00%. This contributed to the annual value of $6.5 million for FY2023, which is 75.68% up from last year.
  • According to the latest figures from Q2 2024, Bicycle Therapeutics' Depreciation and Depletion is $1.6 million, which was down 5.88% from $1.7 million recorded in Q1 2024.
  • In the past 5 years, Bicycle Therapeutics' Depreciation and Depletion ranged from a high of $1.7 million in Q3 2023 and a low of $300,000 during Q1 2020.
  • Its 3-year average for Depreciation and Depletion is $1.4 million, with a median of $1.6 million in 2024.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first plummeted by 50.00% in 2020, then skyrocketed by 333.33% in 2022.
  • Over the past 5 years, Bicycle Therapeutics' Depreciation and Depletion (Quarterly) stood at $400,000 in 2020, then remained steady at $400,000 in 2021, then spiked by 275.00% to $1.5 million in 2022, then increased by 6.67% to $1.6 million in 2023, then remained steady at $1.6 million in 2024.
  • Its Depreciation and Depletion was $1.6 million in Q2 2024, compared to $1.7 million in Q1 2024 and $1.6 million in Q4 2023.